Efficacy and safety of regimens for drug-resistant tuberculosis. (2016)

First Author: Yates TA

Attributed to: Tuberculosis Treatment Trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s1473-3099(16)30390-5

PubMed Identifier: 27788973

Publication URI: http://europepmc.org/abstract/MED/27788973

Type: Journal Article/Review

Volume: 16

Parent Publication: The Lancet. Infectious diseases

Issue: 11

ISSN: 1473-3099